Information Provided By:
Fly News Breaks for February 22, 2019
MDRX
Feb 22, 2019 | 07:59 EDT
Citi analyst Stephanie Demko downgraded Allscripts to Neutral and lowered her price target for the shares to $12 from $14. The "implied steepness" in the ramp to long-term guidance "may prove out of reach," while near-term challenges in investor sentiment could keep shares range bound, Demko tells investors in a post-earnings research note. She points out the stock traded down 11% as a miss on headline numbers and fiscal 2019 guidance "likely struck a raw nerve with investors" following management's bullish tone in January.
News For MDRX From the Last 2 Days
There are no results for your query MDRX